Zynerba (ZYNE) stock forecast for 2026. Forecast tables and graphs.

Zynerba (ZYNE) stock forecast for 2026

The forecast has been updated: October 14, 2021 7:37


Zynerba stock price online today

Analyst Target Price

7.63

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Zynerba stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? Zynerba stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $7.63 target price for Zynerba stock stock.

Today 200 Day Moving Average is the resistance level (4.601 $).

50 Day Moving Average is the resistance level (4.289 $).




ZYNE Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 5.63 4.94 5.92 16.59 %
Feb 5.39 4.91 6.05 18.92 %
Mar 5.51 4.91 6.06 19.00 %
Apr 5.90 5.27 6.70 21.38 %
May 5.29 5.08 5.82 12.61 %
Jun 5.01 4.50 5.47 17.78 %
Jul 5.78 5.51 6.46 14.66 %
Aug 5.90 5.35 6.50 17.63 %
Sep 6.28 5.87 6.62 11.27 %
Oct 5.86 5.24 6.33 17.32 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Zynerba stock.


Zynerba overview

Zynerba Address

80 W. LANCASTER AVENUE, SUITE 300, DEVON, PA, US

Market Capitalization

169 956 000 $

EBITDA

-36 895 716

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-1.082

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

0

Forward PE

0

EV To Revenue

397.61

EV To EBITDA

0

52 Week High

9

52 Week Low

3.15

50 Day Moving Average

4.289

200 Day Moving Average

4.601

Shares Outstanding

41251500

Shares Float

39115800

Shares Short Prior Month

1911700

Short Ratio

0.94

Percent Insiders

2.616

Percent Institutions

39.41

Zynerba stock forecast for this year


Zynerba stock forecast for Jan 2026.
Estimated Average Forecasted Zynerba Price: 5.63. Positive monthly dynamics of the instrument is expected with 16.594% volatility is expected.

Pessimistic forecast: 4.94

Optimistic: 5.92


Zynerba stock forecast for Feb 2026.
Estimated Average Forecasted Zynerba Price: 5.39. Negative monthly dynamics of the instrument is expected with 18.924% volatility is expected.

Pessimistic forecast: 4.91

Optimistic: 6.05


Zynerba stock forecast for Mar 2026.
Estimated Average Forecasted Zynerba Price: 5.51. Positive monthly dynamics of the instrument is expected with 18.999% volatility is expected.

Pessimistic forecast: 4.91

Optimistic: 6.06


Zynerba stock forecast for Apr 2026.
Estimated Average Forecasted Zynerba Price: 5.90. Positive monthly dynamics of the instrument is expected with 21.376% volatility is expected.

Pessimistic forecast: 5.27

Optimistic: 6.70


Zynerba stock forecast for May 2026.
Estimated Average Forecasted Zynerba Price: 5.29. Negative monthly dynamics of the instrument is expected with 12.611% volatility is expected.

Pessimistic forecast: 5.08

Optimistic: 5.82


Zynerba stock forecast for Jun 2026.
Estimated Average Forecasted Zynerba Price: 5.01. Negative monthly dynamics of the instrument is expected with 17.776% volatility is expected.

Pessimistic forecast: 4.50

Optimistic: 5.47


Zynerba stock forecast for Jul 2026.
Estimated Average Forecasted Zynerba Price: 5.78. Positive monthly dynamics of the instrument is expected with 14.664% volatility is expected.

Pessimistic forecast: 5.51

Optimistic: 6.46


Zynerba stock forecast for Aug 2026.
Estimated Average Forecasted Zynerba Price: 5.90. Positive monthly dynamics of the instrument is expected with 17.631% volatility is expected.

Pessimistic forecast: 5.35

Optimistic: 6.50


Zynerba stock forecast for Sep 2026.
Estimated Average Forecasted Zynerba Price: 6.28. Positive monthly dynamics of the instrument is expected with 11.271% volatility is expected.

Pessimistic forecast: 5.87

Optimistic: 6.62


Zynerba stock forecast for Oct 2026.
Estimated Average Forecasted Zynerba Price: 5.86. Negative monthly dynamics of the instrument is expected with 17.317% volatility is expected.

Pessimistic forecast: 5.24

Optimistic: 6.33



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 116.82 (18.10.2021) -0.57 %
AbbVie Inc.
ABBV 107.45 (19.10.2021) 0.02 %
Aeterna Zentaris Inc.
AEZS 0.6051 (18.10.2021) 0.13 %
Allakos Inc.
ALLK 104.04 (18.10.2021) -3.20 %
Allogene Therapeutics, Inc.
ALLO 15.73 (18.10.2021) -4.55 %
Amgen Inc.
AMGN 203.13 (18.10.2021) -2.27 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 14.7 (18.10.2021) -2.78 %
Aurora Cannabis Inc.
ACB 6.92 (18.10.2021) -1.56 %
Becton Dickinson and Company
BDX 238.45 (18.10.2021) -1.12 %
Biogen Inc.
BIIB 268.13 (19.10.2021) -0.59 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 128.99 (18.10.2021) -3.46 %
BioNTech SE
BNTX 261.09 (18.10.2021) 5.41 %
bluebird bio, Inc.
BLUE 21.03 (18.10.2021) 0.62 %
Boston Scientific Corp.
BSX 42.8 (18.10.2021) -1.38 %
Bristol-Myers Squibb Company
BMY 57.59 (19.10.2021) 1.14 %
Canopy Growth Corp.
CGC 13.2 (18.10.2021) -1.12 %
Castle Biosciences, Inc.
CSTL 62.67 (18.10.2021) -1.43 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 238.98 (18.10.2021) 0.46 %
Emergent BioSolutions Inc.
EBS 50.41 (18.10.2021) -0.55 %
Exelixis, Inc.
EXEL 21.5 (19.10.2021) 0.89 %
G1 Therapeutics, Inc.
GTHX 12.52 (18.10.2021) -1.96 %
Gilead Sciences, Inc.
GILD 65.9 (18.10.2021) -2.56 %
GlaxoSmithKline plc
GSK 38.65 (18.10.2021) -0.92 %
GoodRx Holdings, Inc.
GDRX 42.06 (18.10.2021) -0.85 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 65.47 (19.10.2021) 1.38 %
Inovio Pharmaceuticals, Inc.
INO 7.13 (19.10.2021) 1.57 %
Johnson & Johnson
JNJ 163.87 (19.10.2021) 2.34 %
Medtronic plc.
MDT 120.72 (18.10.2021) -5.50 %
Merck & Co., Inc.
MRK 79.49 (19.10.2021) 3.03 %
Moderna, Inc.
MRNA 334.84 (18.10.2021) 3.28 %
Novartis AG
NVS 82.34 (18.10.2021) -1.19 %
Novavax, Inc.
NVAX 166.25 (18.10.2021) 2.66 %
ObsEva SA
OBSV 2.68 (18.10.2021) -2.19 %
OrganiGram Holdings Inc.
OGI 2.36 (19.10.2021) 6.79 %
Pfizer Inc.
PFE 41.32 (18.10.2021) -0.41 %
Regeneron Pharmaceuticals, Inc.
REGN 552.11 (19.10.2021) 1.59 %
Sanofi
SNY 48.03 (18.10.2021) -1.68 %
Schrodinger, Inc.
SDGR 53.24 (18.10.2021) -3.83 %
Senseonics Holdings, Inc.
SENS 3.29 (18.10.2021) -0.30 %
Sorrento Therapeutics, Inc.
SRNE 6.69 (18.10.2021) -2.19 %
Stryker Corp.
SYK 262.05 (18.10.2021) -1.60 %
Sundial Growers Inc.
SNDL 0.6894 (19.10.2021) 5.87 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 9.79 (18.10.2021) 1.14 %
Thermo Fisher Scientific Inc.
TMO 588.03 (18.10.2021) 0.97 %
Tilray, Inc.
TLRY 11.66 (19.10.2021) 15.79 %
UnitedHealth Group, Inc.
UNH 424.62 (18.10.2021) -0.81 %
Veeva Systems Inc.
VEEV 319.24 (19.10.2021) 2.82 %
Zomedica Corp.
ZOM 0.5117 (18.10.2021) 2.03 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.02 (19.10.2021) 3.08 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.